Table 2.

Stool microbiology and parasitology at admission

	Placebo group	N	LGG group	N	P
Rotavirus	33 (39.3%)	84	22 (24.4%)	90	0.052
EPEC	12 (17.6%)	68	9 (13.2%)	68	0.635
Vibrio cholerae	7 (8.0%)	88	11 (12.4%)	89	0.471
Campylobacter sp.	6 (6.8%)	88	9 (10.1%)	89	0.605
Shigella sp.	9 (10.2%)	88	4 (4.5%)	89	0.241
Aeromonas sp.	2 (2.3%)	88	1 (1.1%)	89	0.992
Salmonella sp.	0 (0.0%)	88	1 (1.1%)	89	0.995
Negative microbiology	25 (36.8%)	68	32 (47.1%)	68	0.452
Cryptosporidium parvum	6 (7.0%)	86	2 (2.2%)	89	0.256
Giardia lambliae	2 (2.3%)	86	3 (3.4%)	89	0.969
Strongyloides stercolaris	1 (1.2%)	86	0 (0.0%)	89	0.986
Trichomonas sp.	0 (0.0%)	86	2 (2.2%)	89	0.492
Negative parasitology	77 (89.5%)	86	82 (92.1%)	89	0.738
Negative microbiology and parasitology	22 (35.5%)	62	30 (44.8%)	67	0.371

No patients were found positive for the following parasites: Ascaris, Enterobius, Trichuris, E. hystolytica, Ancylostoma, Necator.

ETEC identification was not done

Values are n (%)